The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
This certification will open new markets for the Kwality Pharma
Exploring new opportunities within the fast-growing market of microfluidics
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Subscribe To Our Newsletter & Stay Updated
